Ark receives licence to manufacture first gene medicine for commercial supply
24-Oct-2005 -
Ark Therapeutics Group plc announced that, following an inspection by the Finnish National Agency for Medicines, on behalf of the European Medicines Agency (EMEA), its facility in Kuopio, Finland has received Good Manufacturing Practice (GMP) Certification to manufacture commercial supplies of ...
brain cancer
China
Finland
+1